Published in J Clin Endocrinol Metab on January 25, 2005
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 12.32
CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest (2005) 10.44
Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 8.92
Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 8.30
Inflamed fat: what starts the fire? J Clin Invest (2006) 3.11
The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol (2011) 2.77
Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci (2010) 2.16
Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med (2012) 2.07
The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev (2012) 2.01
Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring) (2011) 1.90
Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis (2010) 1.60
Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm (2013) 1.59
Transplantation of adipose tissue and stem cells: role in metabolism and disease. Nat Rev Endocrinol (2010) 1.56
Macrophage infiltration into adipose tissue: initiation, propagation and remodeling. Future Lipidol (2008) 1.44
Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes (2008) 1.42
Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care (2009) 1.20
Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exercise. Mediators Inflamm (2013) 1.19
Intrinsic depot-specific differences in the secretome of adipose tissue, preadipocytes, and adipose tissue-derived microvascular endothelial cells. Diabetes (2010) 1.13
Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. ISRN Gastroenterol (2011) 1.12
Macrophages, meta-inflammation, and immuno-metabolism. ScientificWorldJournal (2011) 1.10
Differential intra-abdominal adipose tissue profiling in obese, insulin-resistant women. Obes Surg (2009) 1.10
Insulin resistance, inflammation, and obesity: role of monocyte chemoattractant protein-1 (or CCL2) in the regulation of metabolism. Mediators Inflamm (2010) 1.09
Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection. PLoS Pathog (2015) 1.06
Circulating concentrations of monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, and soluble leukocyte adhesion molecule-1 in overweight/obese men and women consuming fructose- or glucose-sweetened beverages for 10 weeks. J Clin Endocrinol Metab (2011) 1.06
PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice. Cardiovasc Diabetol (2010) 1.02
Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue. Am J Physiol Endocrinol Metab (2008) 1.01
Oxidative stress and the ageing endocrine system. Nat Rev Endocrinol (2013) 1.00
Innate immune activation in obesity. Mol Aspects Med (2012) 0.99
Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells. PLoS One (2013) 0.99
Determination of inflammatory and prominent proteomic changes in plasma and adipose tissue after high-intensity intermittent training in overweight and obese males. J Appl Physiol (1985) (2012) 0.98
Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy. AIDS Res Hum Retroviruses (2013) 0.98
Aging is associated with hypoxia and oxidative stress in adipose tissue: implications for adipose function. Am J Physiol Endocrinol Metab (2011) 0.97
Melanocortin-3 receptor regulates the normal fasting response. Proc Natl Acad Sci U S A (2012) 0.97
Abdominal obesity exhibits distinct effect on inflammatory and anti-inflammatory proteins in apparently healthy Japanese men. Cardiovasc Diabetol (2007) 0.94
Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns. Arch Med Sci (2015) 0.93
Severely obese have greater LPS-stimulated TNF-alpha production than normal weight African-American women. Obesity (Silver Spring) (2008) 0.93
Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapy. Front Endocrinol (Lausanne) (2015) 0.93
Circulating markers of inflammation and their link to indices of adiposity. Obes Facts (2008) 0.93
Adipose tissue and immune function: a review of evidence relevant to HIV infection. J Infect Dis (2013) 0.91
Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders. Front Endocrinol (Lausanne) (2016) 0.91
Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies. Mediators Inflamm (2010) 0.90
The Anti-Inflammatory Actions of Exercise Training. Am J Lifestyle Med (2007) 0.89
Prevention and treatment of type 2 diabetes: current role of lifestyle, natural product, and pharmacological interventions. Pharmacol Ther (2008) 0.89
Subcutaneous adipose tissue in relation to subclinical atherosclerosis and cardiometabolic risk factors in midlife women. Am J Clin Nutr (2011) 0.89
Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat. Front Immunol (2014) 0.88
Effects of LPS and dietary free fatty acids on MCP-1 in 3T3-L1 adipocytes and macrophages in vitro. Nutr Diabetes (2014) 0.87
Intrinsic features in microRNA transcriptomes link porcine visceral rather than subcutaneous adipose tissues to metabolic risk. PLoS One (2013) 0.86
Thrombin increases inflammatory cytokine and angiogenic growth factor secretion in human adipose cells in vitro. J Inflamm (Lond) (2009) 0.86
Tenomodulin promotes human adipocyte differentiation and beneficial visceral adipose tissue expansion. Nat Commun (2016) 0.85
First evidence for the anti-inflammatory activity of fucoxanthin in high-fat-diet-induced obesity in mice and the antioxidant functions in PC12 cells. Inflammation (2014) 0.85
The macrophage at the intersection of immunity and metabolism in obesity. Diabetol Metab Syndr (2011) 0.84
Fat cell size and adipokine expression in relation to gender, depot, and metabolic risk factors in morbidly obese adolescents. Obesity (Silver Spring) (2013) 0.84
Regional differences in subcutaneous adipose tissue gene expression. Obesity (Silver Spring) (2012) 0.83
Circulating levels of 8 cytokines and marine n-3 fatty acids and indices of obesity in Japanese, white, and Japanese American middle-aged men. J Interferon Cytokine Res (2010) 0.82
Association of monocyte chemoattractant protein-1 with adipocyte number, insulin resistance and liver function markers. J Med Primatol (2009) 0.82
Ethnic differences in the effects of hepatic fat deposition on insulin resistance in nonobese middle school girls. Obesity (Silver Spring) (2013) 0.82
Impact of adiposity on cellular adhesion: The Multi-Ethnic Study of atherosclerosis (MESA). Obesity (Silver Spring) (2015) 0.80
Adaptive Immunity and Antigen-Specific Activation in Obesity-Associated Insulin Resistance. Mediators Inflamm (2015) 0.80
Combined ethanol extract of grape pomace and omija fruit ameliorates adipogenesis, hepatic steatosis, and inflammation in diet-induced obese mice. Evid Based Complement Alternat Med (2013) 0.80
Obesity and insulin resistance: an ongoing saga. Diabetes (2010) 0.79
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet. Oncotarget (2016) 0.79
Abdominal obesity: causal factor or simply a symptom of obesity-related health risk. Diabetes Metab Syndr Obes (2014) 0.79
Role of innate and adaptive immunity in obesity-associated metabolic disease. J Clin Invest (2017) 0.78
θ-Defensin RTD-1 improves insulin action and normalizes plasma glucose and FFA levels in diet-induced obese rats. Am J Physiol Endocrinol Metab (2015) 0.78
Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome. Metabolism (2015) 0.78
Differential association of S100A9, an inflammatory marker, and p53, a cell cycle marker, expression with epicardial adipocyte size in patients with cardiovascular disease. Inflammation (2014) 0.78
Plasma NOV/CCN3 levels are closely associated with obesity in patients with metabolic disorders. PLoS One (2013) 0.78
High-carbohydrate diet selectively induces tumor necrosis factor-α production in mice liver. Inflammation (2011) 0.78
Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization. J Vasc Surg (2014) 0.77
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of Flavonoids. Int J Mol Sci (2016) 0.77
Fatty acids induce leukotriene C4 synthesis in macrophages in a fatty acid binding protein-dependent manner. Biochim Biophys Acta (2013) 0.77
An association between adiposity and serum levels of macrophage inflammatory protein-1α and soluble CD14 in HIV-infected adults: results from a cross-sectional study. Antivir Ther (2013) 0.77
A Potential Role for Pro-Inflammatory Cytokines in the Development of Insulin Resistance in Horses. Animals (Basel) (2012) 0.77
LXR activation by GW3965 alters fat tissue distribution and adipose tissue inflammation in ob/ob female mice. J Lipid Res (2013) 0.77
Hyperglycemia and Inflammatory Property of Circulating Monocytes are Associated with Inflammatory Property of Carotid Plaques in Patients Undergoing Carotid Endarterectomy. J Atheroscler Thromb (2016) 0.76
Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men. Mediators Inflamm (2013) 0.76
Gender Differences in Adipocyte Metabolism and Liver Cancer Progression. Front Genet (2016) 0.76
Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients. Mediators Inflamm (2010) 0.76
Characterization of stromal vascular fraction and adipose stem cells from subcutaneous, preperitoneal and visceral morbidly obese human adipose tissue depots. PLoS One (2017) 0.75
Increased density of inhibitory noradrenergic parenchymal nerve fibers in hypertrophic islets of Langerhans of obese mice. Nutr Metab Cardiovasc Dis (2013) 0.75
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury. Front Pharmacol (2016) 0.75
Monocyte chemoattractant protein-1 in adipose tissue. J Clin Endocrinol Metab (2005) 0.75
Relationship key factor of inflammation and the development of complications in the late period of myocardial infarction in patients with visceral obesity. BMC Cardiovasc Disord (2017) 0.75
miR-34a(-/-) mice are susceptible to diet-induced obesity. Obesity (Silver Spring) (2016) 0.75
Monocyte chemotactic protein-1 deficiency attenuates and high-fat diet exacerbates bone loss in mice with Lewis lung carcinoma. Oncotarget (2017) 0.75
Intermuscular adipose tissue is associated with monocyte chemoattractant protein-1, independent of visceral adipose tissue. Clin Biochem (2015) 0.75
Crosstalk between immune cells and adipocytes requires both paracrine factors and cell contact to modify cytokine secretion. PLoS One (2013) 0.75
No differential effect of beverages sweetened with fructose, high-fructose corn syrup, or glucose on systemic or adipose tissue inflammation in normal-weight to obese adults: a randomized controlled trial. Am J Clin Nutr (2016) 0.75
Genetically modified flax expressing NAP-SsGT1 transgene: examination of anti-inflammatory action. Int J Mol Sci (2014) 0.75
AICAR Attenuates TNFα-Induced Inappropriate Secretion of Monocyte Chemoattractant Protein-1 and Adiponectin in 3T3-L1 Adipocytes. J Atheroscler Thromb (2016) 0.75
Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice. Mol Ther Nucleic Acids (2016) 0.75
Macrophage functions in lean and obese adipose tissue. Metabolism (2017) 0.75
Synergistic modulation of inflammatory but not metabolic effects of high-fat feeding by CCR2 and CX3CR1. Obesity (Silver Spring) (2017) 0.75
Adipose Tissue in HIV Infection. Compr Physiol (2017) 0.75
Age increases MCP-1 level in association with bariatric surgery operating time and metabolic risk severity. Obes Sci Pract (2017) 0.75
Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab (2005) 2.77
Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab (2003) 2.71
Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study. Am J Clin Nutr (2011) 2.47
Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes (2002) 1.69
Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol (2004) 1.64
A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes (2002) 1.57
Exercise training versus diet-induced weight-loss on metabolic risk factors and inflammatory markers in obese subjects: a 12-week randomized intervention study. Am J Physiol Endocrinol Metab (2010) 1.46
Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Endocrinol Metab (2003) 1.43
Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab (2004) 1.37
Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrinol (2003) 1.26
Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. Eur J Endocrinol (2008) 1.26
Fasting, but not exercise, increases adipose triglyceride lipase (ATGL) protein and reduces G(0)/G(1) switch gene 2 (G0S2) protein and mRNA content in human adipose tissue. J Clin Endocrinol Metab (2011) 1.23
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. Eur J Endocrinol (2007) 1.20
Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol (2002) 1.18
Diet-induced weight loss and exercise alone and in combination enhance the expression of adiponectin receptors in adipose tissue and skeletal muscle, but only diet-induced weight loss enhanced circulating adiponectin. J Clin Endocrinol Metab (2009) 1.15
AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochem Biophys Res Commun (2004) 1.14
Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity (Silver Spring) (2006) 1.13
Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab (2003) 1.11
Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity: implications for atherogenesis. Circulation (2004) 1.07
Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab (2011) 1.04
Resveratrol in metabolic health: an overview of the current evidence and perspectives. Ann N Y Acad Sci (2013) 1.01
Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2- to 4-year follow-up. Obesity (Silver Spring) (2007) 1.01
Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. Tissue Eng (2004) 1.00
GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus. Am J Physiol Endocrinol Metab (2006) 0.99
Survival following a metformin overdose of 63 g: a case report. Pharmacol Toxicol (2003) 0.99
Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients. Eur J Endocrinol (2004) 0.99
Association between dietary glycemic index, glycemic load, and body mass index in the Inter99 study: is underreporting a problem? Am J Clin Nutr (2006) 0.97
The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss. Obesity (Silver Spring) (2013) 0.96
Reduced mRNA and protein expression of perilipin A and G0/G1 switch gene 2 (G0S2) in human adipose tissue in poorly controlled type 2 diabetes. J Clin Endocrinol Metab (2012) 0.96
11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) (2007) 0.96
Zinc-transporter genes in human visceral and subcutaneous adipocytes: lean versus obese. Mol Cell Endocrinol (2006) 0.96
Artificial sweeteners: a place in the field of functional foods? Focus on obesity and related metabolic disorders. Curr Opin Clin Nutr Metab Care (2012) 0.95
Prolonged erythropoietin treatment does not impact gene expression in human skeletal muscle. Muscle Nerve (2015) 0.94
Comparable reduction of the visceral adipose tissue depot after a diet-induced weight loss with or without aerobic exercise in obese subjects: a 12-week randomized intervention study. Eur J Endocrinol (2009) 0.92
Resveratrol has inhibitory effects on the hypoxia-induced inflammation and angiogenesis in human adipose tissue in vitro. Eur J Pharm Sci (2013) 0.92
[Severe iron-deficiency anaemia after gastric bypass]. Ugeskr Laeger (2014) 0.92
Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment. Clin Endocrinol (Oxf) (2009) 0.92
Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. Nutr Res (2012) 0.91
Opposite regulation of interleukin-8 and tumor necrosis factor-alpha by weight loss. Obes Res (2002) 0.91
Rosiglitazone decreases bone mass and bone marrow fat. J Clin Endocrinol Metab (2011) 0.91
Long-term weight loss decreases the nontraditional cardiovascular risk factors interleukin-18 and matrix metalloproteinase-9 in obese subjects. Metabolism (2009) 0.90
[Hypoglycaemia after gastric bypass is a challenge to diagnostic procedures and treatment]. Ugeskr Laeger (2014) 0.90
Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J Lipid Res (2011) 0.89
The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells. Mol Cell Endocrinol (2008) 0.89
Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy. Metabolism (2006) 0.89
Differential impact of acute and chronic lipotoxicity on gene expression in INS-1 cells. Metabolism (2002) 0.88
Differential effects of dietary protein sources on postprandial low-grade inflammation after a single high fat meal in obese non-diabetic subjects. Nutr J (2011) 0.88
Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load. PLoS One (2011) 0.87
Acute exercise increases circulating inflammatory markers in overweight and obese compared with lean subjects. Eur J Appl Physiol (2013) 0.87
Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index--a cross-sectional study. J Pediatr (2004) 0.87
Impact of growth hormone receptor blockade on substrate metabolism during fasting in healthy subjects. J Clin Endocrinol Metab (2009) 0.86
Whole body metabolic effects of prolonged endurance training in combination with erythropoietin treatment in humans: a randomized placebo controlled trial. Am J Physiol Endocrinol Metab (2013) 0.85
Evaluation of functional erythropoietin receptor status in skeletal muscle in vivo: acute and prolonged studies in healthy human subjects. PLoS One (2012) 0.85
Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trial. J Clin Endocrinol Metab (2012) 0.83
Growth hormone (GH) substitution in GH-deficient patients inhibits 11beta-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. J Clin Endocrinol Metab (2005) 0.82
Anti-glucocorticoid effects of progesterone in vivo on rat adipose tissue metabolism. Steroids (2003) 0.81
Erythropoietin administration acutely stimulates resting energy expenditure in healthy young men. J Appl Physiol (1985) (2012) 0.81
Direct effects of locally administered lipopolysaccharide on glucose, lipid, and protein metabolism in the placebo-controlled, bilaterally infused human leg. J Clin Endocrinol Metab (2013) 0.81
Exercise and fasting activate growth hormone-dependent myocellular signal transducer and activator of transcription-5b phosphorylation and insulin-like growth factor-I messenger ribonucleic acid expression in humans. J Clin Endocrinol Metab (2010) 0.81
Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study. Diabetes (2012) 0.81
Depleted skeletal muscle mitochondrial DNA, hyperlactatemia, and decreased oxidative capacity in HIV-infected patients on highly active antiretroviral therapy. J Med Virol (2005) 0.80
Pro- and mature IGF-II during diet-induced weight loss in obese subjects. Eur J Endocrinol (2005) 0.79
Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen. Obesity (Silver Spring) (2008) 0.79
Acute and short-term chronic testosterone fluctuation effects on glucose homeostasis, insulin sensitivity, and adiponectin: a randomized, double-blind, placebo-controlled, crossover study. J Clin Endocrinol Metab (2014) 0.79
Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution. Clin Endocrinol (Oxf) (2007) 0.78
Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial. Obesity (Silver Spring) (2008) 0.78
[Prevention and treatment of obesity in children]. Ugeskr Laeger (2006) 0.78
Ethanol exerts anti-inflammatory effects in human adipose tissue in vitro. Mol Cell Endocrinol (2008) 0.78
The effect of high-dose vitamin D supplementation on calciotropic hormones and bone mineral density in obese subjects with low levels of circulating 25-hydroxyvitamin d: results from a randomized controlled study. Calcif Tissue Int (2013) 0.78
[Prevention of obesity among children and adolescents--proposal for a strategy]. Ugeskr Laeger (2007) 0.78
Effects of a meal rich in medium-chain saturated fat on postprandial lipemia in relatives of type 2 diabetics. Nutrition (2013) 0.78
Intact pituitary function is decisive for the catabolic response to TNF-α: studies of protein, glucose and fatty acid metabolism in hypopituitary and healthy subjects. J Clin Endocrinol Metab (2014) 0.77
Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity. Clin Endocrinol (Oxf) (2008) 0.77
[Monitoring the prevalence of obesity]. Ugeskr Laeger (2008) 0.77